|
|
News Breaks | | | | October 25, 2012 | | 08:08 EDT |  | RTIX | RTI Biologics says working with FDA to address concerns
On Oct. 23, 2012 the company received a warning letter from the FDA related to environmental monitoring activities in certain areas of its Alachua, Fla. processing facility. The company is committed to actively working with the FDA to address their concerns. The warning letter does not restrict the company’s ability to process or distribute implants, nor does it require the withdrawal of any implants from the marketplace. The issuance of the warning letter has no impact on patient safety. | |
|
News For RTIX From The Last 14 Days Check below for free stories on RTIX the last two weeks. |
|
|
| May 23, 2013 | | 15:03 EDT | | RTIX | RTI Biologics reports milestone in tissue development
RTI Biologics announces that the company has passed the five million mark in distributing implants sterilized through its patented, validated tissue sterilization processes, BioCleanse, Tutoplast and Cancelle SP, with zero incidence of implant-associated infection. | |
|
|
|
|
|
|
